Navigation Links
Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article

The newest therapy to receive orphan drug status for the treatment of malignant pleural mesothelioma will not be available for general use any time soon, according to educational website Surviving Mesothelioma. Click here to read their article on MTG-201.

MTG-201, a biologic therapy that received orphan drug designation for mesothelioma last week from the FDA, will now head into Phase I clinical trials to establish its safety and efficacy in human patients.

“Although MTG-201’s orphan drug designation may help speed its development, it and other orphan drugs must still go through clinical trials before doctors can prescribe them for their mesothelioma patients,” says Surviving Mesothelioma’s Managing Editor, Alex Strauss.

According to the San Francisco-based company that makes MTG-201, the new treatment works by targeting a particular gene defect that can prevent mesothelioma cells from going through the cell death cycle like normal cells. It may also trigger an anti-mesothelioma immune system response.

Orphan drug status, which was established by the Orphan Drug Act of 1983, can be granted to drugs designed to treat diseases effecting fewer than 200,000 people.

To better understand how orphan drug status could impact the development of MTG-201 and how mesothelioma patients can be involved, see Putting the Newest Mesothelioma “Orphan Drug” Into Perspective, now available on the Surviving Mesothelioma website.

Company Press Release, “MTG Biotherapeutics Announces that MTG-201 was Granted Orphan Drug Designation by the US FDA for the Treatment of Malignant Mesothelioma”, August 21, 2015,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientists Say Enzymes May Influence Chemotherapy Response in Mesothelioma, According to Surviving Mesothelioma
2. New Research Unveils Potential Method for Improved Response to Mesothelioma Drug, According to Surviving Mesothelioma
3. Survey Finds Some Physicians Inadequately Trained to Diagnose and Manage Mesothelioma, According to Surviving Mesothelioma
4. New Study Quantifies Mesothelioma Risk After Closure of Asbestos Industry, According to Surviving Mesothelioma
5. New Trial Will Test Virus-Delivered Treatment for Mesothelioma, According to Surviving Mesothelioma
6. Mesothelioma Growth in Mice Slowed by Kidney Drug in New Study, According to Surviving Mesothelioma
7. New Report Focuses on the Complex Process of Mesothelioma Diagnosis, According to Surviving Mesothelioma
8. New Mesothelioma Treatment Guidelines Issued By European Researchers, According to Surviving Mesothelioma
9. New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma
10. Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma
11. Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma
Post Your Comments:
(Date:4/1/2020)... ... April 01, 2020 , ... Velocidy Bio ’s Dutch biotech partner, ... that decreases the testing time for SARS-CoV-2 to eight minutes, compared to current ... of a shoebox could perform a hundred and eighty (180) amplification runs a day, ...
(Date:3/30/2020)... DOWNERS GROVE, Ill. (PRWEB) , ... March 30, ... ... to its name as the coronavirus pandemic sweeps the country. In an effort ... the company’s software solutions are enabling police interaction with community members while minimizing ...
(Date:3/28/2020)... ... March 27, 2020 , ... To help prevent the spread ... as an alternative approach to seeing their patients. This approach will allow patients ... their own home or office using video conference and telecommunications technology, such as ...
(Date:3/27/2020)... (PRWEB) , ... March 27, 2020 , ... ... reviewed and approved by NJ Top Docs. Dr. Kubeck has been approved every ... of Orthopaedic Surgery and specializes in Spinal Surgery. , Dr. Kubeck’s medical ...
(Date:3/22/2020)... ... March 21, 2020 , ... The modular construction industry, ... Association (MHBA), have been working with state and federal officials on ways to ... greater use of modular construction to address the nation’s affordable housing crisis well ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... April 02, 2020 , ... On April 15, ... initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global clinical research ... healthcare professionals, researchers and study volunteers. CISCRP invites the public to participate ...
(Date:4/1/2020)... ... April 01, 2020 , ... As the coronavirus pandemic ... care and accessible primary care, launches its telemedicine platform, AFC/TeleCare, as a solution ... now provide virtual visits, allowing our medical providers to easily connect with patients ...
(Date:3/30/2020)... (PRWEB) , ... March 30, 2020 , ... ... is launching a new solution, . By leveraging technology developed ... providers of all sizes to continue offering revenue-generating healthcare services while serving patients’ ...
Breaking Medicine Technology: